• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩散磁共振成像:肿瘤治疗反应的生物标志物

Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology.

作者信息

Hamstra Daniel A, Rehemtulla Alnawaz, Ross Brian D

机构信息

Department of Radiation Oncology, The Center for Molecular Imaging, University of Michigan Medical Center, Ann Arbor, MI 48109-2200, USA.

出版信息

J Clin Oncol. 2007 Sep 10;25(26):4104-9. doi: 10.1200/JCO.2007.11.9610.

DOI:10.1200/JCO.2007.11.9610
PMID:17827460
Abstract

Imaging of response to oncology treatments, either on clinical protocol or as part of standard practice, is a complicated process that has evolved during the last 10 years due to the improvement of existing imaging technologies and the introduction of newer modalities. Diffusion magnetic resonance imaging is a technique that measures the mobility of water within tissues and, as such, may function as a surrogate marker for both tissue cellularity and response to treatment that occur earlier than usual measures of tumor response. This review highlights the development of this technique and the state of current clinical understanding of its utility.

摘要

对肿瘤治疗反应的成像,无论是作为临床方案的一部分还是作为标准实践的一部分,都是一个复杂的过程。在过去十年中,由于现有成像技术的改进和更新模式的引入,这一过程不断发展。扩散磁共振成像是一种测量组织内水分子运动的技术,因此,它可以作为组织细胞密度和治疗反应的替代标志物,其出现时间比通常的肿瘤反应测量指标更早。这篇综述重点介绍了该技术的发展以及目前临床对其效用的理解状况。

相似文献

1
Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology.扩散磁共振成像:肿瘤治疗反应的生物标志物
J Clin Oncol. 2007 Sep 10;25(26):4104-9. doi: 10.1200/JCO.2007.11.9610.
2
Tumor response evaluation in oncology: current update.肿瘤学中的肿瘤反应评估:当前进展
J Comput Assist Tomogr. 2010 Jul;34(4):479-84. doi: 10.1097/RCT.0b013e3181db2670.
3
An Update on the Role of Cardiac Magnetic Resonance Imaging in Cancer Patients.心脏磁共振成像在癌症患者中的作用最新进展
Curr Cardiol Rep. 2022 Dec;24(12):2139-2147. doi: 10.1007/s11886-022-01818-x. Epub 2022 Nov 7.
4
Imaging in Oncology--SMi's Inaugural Conference. 17-18 March 2004, London, UK.肿瘤学影像学——SMi首届会议。2004年3月17 - 18日,英国伦敦
IDrugs. 2004 May;7(5):444-6.
5
Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.肿瘤学中的全身磁共振成像和正电子发射断层扫描-计算机断层扫描
Top Magn Reson Imaging. 2007 Jun;18(3):193-202. doi: 10.1097/RMR.0b013e318093e6bo.
6
Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development.磁共振成像的表观扩散系数作为肿瘤药物开发的生物标志物。
Eur J Cancer. 2012 Mar;48(4):425-31. doi: 10.1016/j.ejca.2011.11.034. Epub 2012 Jan 5.
7
Functional magnetic resonance imaging in cervical cancer: current evidence and future directions.宫颈癌中的功能磁共振成像:当前证据与未来方向。
J Cancer Res Ther. 2012 Jan-Mar;8(1):11-8. doi: 10.4103/0973-1482.95167.
8
Plasmacytoma of the skull.
Eur J Haematol. 2012 Apr;88(4):369. doi: 10.1111/j.1600-0609.2011.01714.x. Epub 2011 Nov 15.
9
Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.技术洞察:水扩散磁共振成像——一种癌症治疗反应的潜在新生物标志物。
Nat Clin Pract Oncol. 2008 Apr;5(4):220-33. doi: 10.1038/ncponc1073. Epub 2008 Feb 26.
10
New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.癌症治疗的新靶点与靶向药物:儿科肿瘤学展望
Pediatr Hematol Oncol. 2011 Oct;28(7):539-55. doi: 10.3109/08880018.2011.613094.

引用本文的文献

1
Application of artificial intelligence chatbots in interpreting magnetic resonance imaging reports: a comparative study.人工智能聊天机器人在解读磁共振成像报告中的应用:一项对比研究。
Sci Rep. 2025 Aug 25;15(1):31266. doi: 10.1038/s41598-025-17355-w.
2
Tremelimumab plus Durvalumab prior to Chemoradiotherapy in Unresectable, Locally Advanced Non-Small Cell Lung Cancer: The Induction Trial.度伐利尤单抗联合曲美木单抗用于不可切除的局部晚期非小细胞肺癌放化疗前诱导治疗的研究
Clin Cancer Res. 2025 Mar 17;31(6):1037-1046. doi: 10.1158/1078-0432.CCR-24-3476.
3
The apparent diffusion coefficient can serve as a predictor of survival in patients with gliomas.
表观扩散系数可作为预测脑胶质瘤患者生存情况的指标。
Radiat Oncol. 2024 Oct 29;19(1):149. doi: 10.1186/s13014-024-02535-1.
4
Utility of interim apparent diffusion coefficient value in predicting treatment response among patients with locally advanced cervical cancer treated with radiotherapy.局部晚期宫颈癌患者放疗期间表观扩散系数值中期预测治疗反应的效用
Clin Transl Radiat Oncol. 2024 Jul 28;48:100827. doi: 10.1016/j.ctro.2024.100827. eCollection 2024 Sep.
5
Delta-radiomics features of ADC maps as early predictors of treatment response in lung cancer.作为肺癌治疗反应早期预测指标的ADC图的Delta放射组学特征
Insights Imaging. 2024 Aug 26;15(1):218. doi: 10.1186/s13244-024-01787-5.
6
Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer.表观弥散系数值可预测巨块型宫颈癌近距离放疗的疗效。
Radiat Oncol. 2024 Mar 13;19(1):35. doi: 10.1186/s13014-024-02425-6.
7
An open relaxation-diffusion MRI dataset in neurosurgical studies.神经外科研究中的开放弛豫-扩散 MRI 数据集。
Sci Data. 2024 Feb 7;11(1):177. doi: 10.1038/s41597-024-03013-9.
8
Texture Analysis of the Apparent Diffusion Coefficient Focused on Contrast-Enhancing Lesions in Predicting Survival for Bevacizumab-Treated Patients with Recurrent Glioblastoma.聚焦于对比增强病变的表观扩散系数纹理分析在预测贝伐单抗治疗的复发性胶质母细胞瘤患者生存率中的应用
Cancers (Basel). 2023 Jun 1;15(11):3026. doi: 10.3390/cancers15113026.
9
Clinical Applications of Magnetic Resonance-Guided Radiotherapy: A Narrative Review.磁共振引导放疗的临床应用:一项叙述性综述
Cancers (Basel). 2023 May 26;15(11):2916. doi: 10.3390/cancers15112916.
10
Update in Imaging Evaluation of Bone and Soft Tissue Sarcomas.骨与软组织肉瘤的影像学评估进展
Rev Bras Ortop (Sao Paulo). 2021 Nov 11;58(2):179-190. doi: 10.1055/s-0041-1736569. eCollection 2023 Apr.